Summary
Acorda Therapeutics, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Acorda Therapeutics, Inc. (Acorda or 'the company') is engaged in the identification, development and commercialization of novel therapies to treat neurological disorders. It is also engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company also offers various pipeline products to neurological therapies including heart failure, migraine, Primary Sclerosing Cholangitis, MS, spinal cord injury and various other disorders. Acorda's product portfolio are marketed under Zanaflex, Ampyra or Fampyra (dalfampridine); Inbrija, BTT1023, and GGF2. It develops additional inhaled medicines for both systemic and pulmonary conditions. Acorda primarily operates in the US. The company is headquartered in Ardsley, New York, the US
Scope
- Detailed information on Acorda Therapeutics, Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Acorda Therapeutics, Inc in the form of a SWOT analysis
- An in-depth view of the business model of Acorda Therapeutics, Inc including a breakdown and examination of key business segments
- Intelligence on Acorda Therapeutics, Inc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Acorda Therapeutics, Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Acorda Therapeutics, Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Acorda Therapeutics, Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Acorda Therapeutics, Inc's business structure, strategy and prospects.
'
Table of Contents
Company Snapshot
Acorda Therapeutics, Inc.: Company Overview
Acorda Therapeutics, Inc.: Overview and Key Facts
Acorda Therapeutics, Inc.: Overview
Acorda Therapeutics, Inc.: Key Facts
Acorda Therapeutics, Inc.: Key Employees
Acorda Therapeutics, Inc.: Key Employee Biographies
Acorda Therapeutics, Inc.: Major Products and Services
Acorda Therapeutics, Inc.: Company History
Acorda Therapeutics, Inc.: Management Statement
Acorda Therapeutics, Inc.: Locations and Subsidiaries
Acorda Therapeutics, Inc.: Key Competitors
Acorda Therapeutics, Inc.: Company Analysis
Acorda Therapeutics, Inc.: Business Description
Acorda Therapeutics, Inc.: SWOT Analysis
Acorda Therapeutics, Inc.: SWOT Overview
Acorda Therapeutics, Inc.: Strengths
Acorda Therapeutics, Inc.: Weaknesses
Acorda Therapeutics, Inc.: Opportunities
Acorda Therapeutics, Inc.: Threats
Acorda Therapeutics, Inc.: Corporate Financial Deals Activity
Acorda Therapeutics, Inc.: Financial Deals Overview
Acorda Therapeutics, Inc.: Targets and Partners
Acorda Therapeutics, Inc.: Top Deals 2018 - 2022YTD*
Acorda Therapeutics, Inc.: Advisors
Acorda Therapeutics, Inc.: Top Legal Advisors
Acorda Therapeutics, Inc.: Top Financial Advisors
Acorda Therapeutics, Inc.: Capital Raising
Acorda Therapeutics, Inc.: Partnership
Acorda Therapeutics, Inc.: Divestments
Acorda Therapeutics, Inc.: Recent Developments
Acorda Therapeutics, Inc.: News and Events Summary
Acorda Therapeutics, Inc.: Contracts
Acorda Therapeutics, Inc.: Corporate Governance
Acorda Therapeutics, Inc.: Financial Deals
Acorda Therapeutics, Inc.: Financial Performance
Acorda Therapeutics, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Acorda Therapeutics, Inc.: Key Facts
Table 2: Acorda Therapeutics, Inc.: Key Employees
Table 3: Acorda Therapeutics, Inc.: Company History
Table 4: Acorda Therapeutics, Inc.: Locations and Subsidiaries
Table 5: Acorda Therapeutics, Inc.: Key Competitors
Table 6: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 8: Acorda Therapeutics, Inc.: Targets and Partners
Table 9: Acorda Therapeutics, Inc.: Top Deals 2018 - 2022YTD*
Table 10: Acorda Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Acorda Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Acorda Therapeutics, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 13: Acorda Therapeutics, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 14: Acorda Therapeutics, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 15: Acorda Therapeutics, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 16: Acorda Therapeutics, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 17: Acorda Therapeutics, Inc.: News and Events Summary
Table 18: Acorda Therapeutics, Inc.: Contracts
Table 19: Acorda Therapeutics, Inc.: Corporate Governance
Table 20: Acorda Therapeutics, Inc.: Financial Deals
Table 21: Acorda Therapeutics, Inc.: Financial Performance
Table 22: Acorda Therapeutics, Inc.: Strategy and Operations
List of Figures
Figure 1: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 3: Acorda Therapeutics, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 4: Acorda Therapeutics, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 5: Acorda Therapeutics, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 6: Acorda Therapeutics, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 7: Acorda Therapeutics, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
